Vivos Therapeutics, Inc. Sustainability Profile
Vivos Therapeutics, Inc., a pioneering company in the field of sleep-disordered breathing, is headquartered in the United States. Founded in 2016, Vivos has rapidly established itself as a leader in the dental and medical industries, focusing on innovative solutions for obstructive sleep apnoea (OSA) and related conditions. The company’s flagship product, the Vivos System, offers a unique, non-invasive approach to treating OSA by addressing the underlying anatomical issues rather than merely alleviating symptoms. This distinctive methodology sets Vivos apart in a competitive market, contributing to its growing reputation and market position. With a commitment to improving patient outcomes, Vivos Therapeutics continues to expand its operational reach, making significant strides in the realm of sleep health.
DitchCarbon Score
How does Vivos Therapeutics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Vivos Therapeutics, Inc.'s score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Vivos Therapeutics, Inc.'s reported carbon emissions
Vivos Therapeutics, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Vivos Therapeutics may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). As a result, the company's climate commitments remain unclear, and it appears to be operating without a defined strategy for addressing carbon emissions or sustainability.
How Carbon Intensive is Vivos Therapeutics, Inc.'s Industry?
How Carbon Intensive is Vivos Therapeutics, Inc.'s Location?
Vivos Therapeutics, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Vivos Therapeutics, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
